Since its discovery in 1984 by Svetlana Mosjov, GLP-1 and its analogs (such as semaglutide, liraglutide, and dulaglutide) have rapidly become cornerstone treatments for type 2 diabetes mellitus (T2DM) and obesity
Unlike single-receptor compounds, retatrutide interacts with three important metabolic signaling pathways: GLP-1 receptor GIP receptor glucagon receptor Different parts of metabolic regulation are affected by each pathway A lot of research has been done on how activating GLP-1 receptors affects glucose-dependent insulin secretion, controlling appetite, and emptying the stomach
Recent studies have also shown that ECM remodeling is crucial for diabetic complications to arise
Glutathione l cht chng oxy ha mnh m
In November 2023, tirzepatide was also approved for chronic weight management in adults with obesity or overweight and at least one weight-related comorbidity
The standard protocol starts at 1mg weekly for 4 weeks, then titrates up monthly: 2mg, 4mg, 8mg, reaching 12mg maintenance